Efg Asset Management (Americas) Corp. Rocket Pharmaceuticals, Inc. Transaction History

Efg Asset Management (Americas) Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$26.16 - $30.74 $116,987 - $137,469	-4,472 Reduced 37.35%	7,500 $202,000
Q4 2023 Feb 01, 2024	SELL	$16.78 - $31.94 $14,565 - $27,723	-868 Reduced 6.76%	11,972 $358,000
Q3 2023 Nov 09, 2023	BUY	$15.07 - $24.05 $17,014 - $27,152	1,129 Added 9.64%	12,840 $263,000
Q2 2023 Aug 29, 2023	BUY	$16.59 - $23.6 $13,753 - $19,564	829 Added 7.62%	11,711 $232,000
Q1 2023 May 04, 2023	BUY	$15.79 - $22.6 $171,826 - $245,933	10,882 New	10,882 $186,000

213

93.1M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $851M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.